CLBCore Laboratories Inc.
Price
-15%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, nothing alarming, price roughly fair, growth fading, the market against it.
Charts
As reported to the SEC, without any scoring.
Core Laboratories Inc. (CLB) reported revenue of $125M in Q2 2026 (quarter ended Jun 30, 2026), down 4.3% from the same quarter a year earlier. That came with a gross margin of 19% and net income of $6.0M (4.8% of revenue). For the full year FY2025, revenue was $527M (+0.5% year on year) and net income $30M. The next results filing is expected around Oct 21, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 25, 2026On August 19, 2026, Kwaku Temeng verbally notified the Board of Directors of Core Laboratories Inc. (the “Company”) of his intention to resign as a director of the Company effective October 1, 2026.Director or officer change · Form 8-K
- Jul 29, 2026Liquidity, Free Cash Flow, Share Repurchases, and Dividend.Earnings release · press release
- Apr 29, 2026Liquidity, Free Cash Flow, Share Repurchases, and Dividend.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.